Literature DB >> 19185006

Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model.

Brigid Joseph1, Sorabh Kapoor, Michael L Schilsky, Sanjeev Gupta.   

Abstract

Insights into disease-specific mechanisms for liver repopulation are needed for cell therapy. To understand the efficacy of pro-oxidant hepatic perturbations in Wilson disease, we studied Long-Evans Cinnamon (LEC) rats with copper toxicosis under several conditions. Hepatocytes from healthy Long-Evans Agouti (LEA) rats were transplanted intrasplenically into the liver. A cure was defined as lowering of copper to below 250 microg/g liver, presence of ATPase, Cu++ transporting, beta polypeptide (atp7b) messenger RNA (mRNA) in the liver and improvement in liver histology. Treatment of animals with the hydrophobic bile salt, cholic acid, or liver radiation before cell transplantation produced cure rates of 14% and 33%, respectively; whereas liver radiation plus partial hepatectomy followed by cell transplantation proved more effective, with cure in 55%, P < 0.01; and liver radiation plus cholic acid followed by cell transplantation was most effective, with cure in 75%, P < 0.001. As a group, cell therapy cures in rats preconditioned with liver radiation plus cholic acid resulted in less hepatic copper, indicating greater extent of liver repopulation. We observed increased hepatic catalase and superoxide dismutase activities in LEC rats, suggesting chronic oxidative stress. After liver radiation or cholic acid, hepatic lipid peroxidation levels increased, indicating further oxidative injury, although we did not observe overt additional cytotoxicity. This contrasted with healthy animals in which liver radiation and cholic acid produced hepatic steatosis and loss of injured hepatocytes. We concluded that pro-oxidant perturbations were uniquely effective for cell therapy in Wilson disease because of the nature of preexisting hepatic damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185006      PMCID: PMC2677114          DOI: 10.1002/hep.22792

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  37 in total

1.  Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events.

Authors:  S H Sigal; P Rajvanshi; G R Gorla; R P Sokhi; R Saxena; D R Gebhard; L M Reid; S Gupta
Journal:  Am J Physiol       Date:  1999-05

2.  Integration and proliferation of transplanted cells in hepatic parenchyma following D-galactosamine-induced acute injury in F344 rats.

Authors:  S Gupta; P Rajvanshi; A N Irani; C J Palestro; K K Bhargava
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

3.  Mechanism of copper-activated transcription: activation of AP-1, and the JNK/SAPK and p38 signal transduction pathways.

Authors:  Michael D Mattie; Matthew K McElwee; Jonathan H Freedman
Journal:  J Mol Biol       Date:  2008-09-09       Impact factor: 5.469

4.  Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease.

Authors:  Alberta Samuele; Anna Mangiagalli; Marie-Thérèse Armentero; Roberto Fancellu; Eleonora Bazzini; Mariapia Vairetti; Andrea Ferrigno; Plinio Richelmi; Giuseppe Nappi; Fabio Blandini
Journal:  Biochim Biophys Acta       Date:  2005-09-25

5.  Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias.

Authors:  Chandan Guha; Kosho Yamanouchi; Jinlan Jiang; Xia Wang; Namita Roy Chowdhury; Alfredo Santana; Lawrence J Shapiro; Eduardo Salido; Jayanta Roy-Chowdhury
Journal:  Am J Nephrol       Date:  2005-04-21       Impact factor: 3.754

6.  Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA.

Authors:  K Terada; T Nakako; X L Yang; M Iida; N Aiba; Y Minamiya; M Nakai; T Sakaki; N Miura; T Sugiyama
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

7.  Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation.

Authors:  C Guha; A Sharma; S Gupta; A Alfieri; G R Gorla; S Gagandeep; R Sokhi; N Roy-Chowdhury; K E Tanaka; B Vikram; J Roy-Chowdhury
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

8.  Complete reconstitution of mouse liver with xenogeneic hepatocytes.

Authors:  J A Rhim; E P Sandgren; R D Palmiter; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Possible involvement of MAP kinase pathways in acquired metal-tolerance induced by heat in plants.

Authors:  Po-Yu Chen; Kuo-Ting Lee; Wen-Chang Chi; Heribert Hirt; Ching-Chun Chang; Hao-Jen Huang
Journal:  Planta       Date:  2008-05-28       Impact factor: 4.116

10.  Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease.

Authors:  Harmeet Malhi; Brigid Joseph; Michael L Schilsky; Sanjeev Gupta
Journal:  Regen Med       Date:  2008-03       Impact factor: 3.806

View more
  15 in total

1.  In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation With Bone Marrow-Derived Myofibroblasts or Inflammatory Cells and Not Hepatocytes Is Deleterious.

Authors:  Yogeshwar Sharma; Jinghua Liu; Kathleen E Kristian; Antonia Follenzi; Sanjeev Gupta
Journal:  Gene Expr       Date:  2018-07-20

2.  Diagnosis of abnormal biliary copper excretion by positron emission tomography with targeting of (64)Copper-asialofetuin complex in LEC rat model of Wilson's disease.

Authors:  Ralf Bahde; Sorabh Kapoor; Kuldeep K Bhargava; Christopher J Palestro; Sanjeev Gupta
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

3.  Ischemic preconditioning affects long-term cell fate through DNA damage-related molecular signaling and altered proliferation.

Authors:  Sorabh Kapoor; Ekaterine Berishvili; Sriram Bandi; Sanjeev Gupta
Journal:  Am J Pathol       Date:  2014-08-13       Impact factor: 4.307

Review 4.  Animal models of Wilson disease.

Authors:  Emily Reed; Svetlana Lutsenko; Oliver Bandmann
Journal:  J Neurochem       Date:  2018-06-26       Impact factor: 5.372

5.  Demonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat Model.

Authors:  Fadi Luc Jaber; Yogeshwar Sharma; Sanjeev Gupta
Journal:  Methods Mol Biol       Date:  2017

6.  Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytes.

Authors:  Jianqiang Ding; Govardhana R Yannam; Namita Roy-Chowdhury; Tunda Hidvegi; Hesham Basma; Stephen I Rennard; Ronald J Wong; Yesim Avsar; Chandan Guha; David H Perlmutter; Ira J Fox; Jayanta Roy-Chowdhury
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

Review 7.  Therapeutic liver repopulation for phenylketonuria.

Authors:  Cary O Harding; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2010-05-22       Impact factor: 4.982

8.  Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.

Authors:  Jayantee Kalita; Vijay Kumar; Abhay Ranjan; Usha K Misra
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

Review 9.  Cell therapy to remove excess copper in Wilson's disease.

Authors:  Sanjeev Gupta
Journal:  Ann N Y Acad Sci       Date:  2014-05       Impact factor: 5.691

Review 10.  Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.

Authors:  Kara R Vogel; Andrew A Kennedy; Luke A Whitehouse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2013-10-02       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.